Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established constraints. Generative AI turns that on its head. It is an expansive force, ...

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

Appointment brings deep life sciences, clinical, & global market expertise to DiaGen as it scales its AI-driven ...

According to data published by Precedence Research, Generative AI is transforming the life science sector, driving innovation in drug discovery, clinical trials, and manufacturing, while reducing ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.

Karthik Sankaranarayanan trained in two quite different scientific subfields as a graduate student and as a postdoctoral ...

YCT-529 inhibits retinoic acid receptor alpha to suppress sperm production reversibly. Currently in Phase 1b/2a trials, the compound has shown promise in preclinical models and aims to expand ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...